Evaluation of Food-Grade Dent Corn Hybrids for Severity of Fusarium Ear Rot and Fumonisin Accumulation in Grain.

Fumonisins produced by Fusarium verticillioides (syn = F. moniliforme) and F. proliferatum have been associated with potentially serious toxicoses of animals and humans. Thus, hybrids with low fumonisin accumulation in grain will be valuable for the production of corn-based human food products. We evaluated 68 food-grade dent corn hybrids for severity of Fusarium ear rot and fumonisin accumulation in grain in inoculated trials in Urbana, IL in 2000 and 2001. Our inoculation technique was successful in initiating fumonisin accumulation that allowed discrimination among hybrids. We identified several hybrids that could have acceptable levels (<4 µg/g) of fumonisin accumulation in Illinois in most years. Twenty-six hybrids with low or high fumonisin accumulation in 2000 were reevaluated in noninoculated trials at three locations in Illinois in 2001. Fumonisin concentration in grain at all three locations was relatively low; thus, separation of hybrids was poor. At two locations, those hybrids with the highest fumonisin concentration in grain also had high concentrations following inoculation. However, one hybrid that had relatively low fumonisin concentration following inoculation had unacceptable levels of fumonisin (5 µg/g) in natural conditions. Therefore, hybrids need to be evaluated by inoculation and further evaluated at locations where the environment favors fumonisin accumulation.

Sources of resistance to fumonisin accumulation in grain and fusarium ear and kernel rot of corn.

ABSTRACT Fumonisin is a group of homologous mycotoxins produced by several species of Fusarium. Fumonisin has been associated with Fusarium ear and kernel rot of corn (Zea mays) and several toxicoses of animals and humans. Corn inbreds with a high level of resistance to fumonisin production and accumulation in grain have not been identified. The objective of this study was to evaluate a genetically diverse collection of inbreds as potential sources of resistance to fumonisin production and accumulation in grain and Fusarium ear and kernel rot when crossed with a commercial "B73-type" line. F(1) hybrids developed with the inbred FR1064 and 1,589 and 1,030 inbreds were evaluated in inoculated and naturally infected trials, respectively, in 2000. Thirty-five F(1) hybrids with fumonisin concentration in grain of

Evaluation of the MI82 Corn Line as a Source of Resistance to Aflatoxin in Grain and Use of BGYF as a Selection Tool.

Our objectives were to determine if the corn (Zea mays) inbred MI82 has alleles for resistance to Aspergillus ear rot (caused by Aspergillus flavus) and aflatoxin accumulation in grain that can be transferred to commercially used inbreds, and to determine the types and magnitudes of gene action, heritabilities, and gain from selection for low levels of bright greenish-yellow fluorescence (BGYF), aflatoxin, and ear rot with MI82. Also, we hoped to determine if selection against BGYF would substantially reduce the concentration of aflatoxin in grain. Primary ears and ground grain from inbred MI82 (P1), the susceptible inbred B73 (P2), and the F1, F2, F3, BCP1S1, and BCP2S1 generations developed from these inbreds were evaluated for BGYF, concentration of aflatoxin in grain, and severity of Aspergillus ear rot in 2000 and 2001. Dominance was the most important gene action associated with low levels of BGYF and a low concentration of aflatoxin in grain. Heritabilities for low levels of BGYF (83.5%), aflatoxin (74.1%), and ear rot (62.8%) were high. Correlation coefficients between aflatoxin and BGYF were high in both years (r = 0.75 and 0.79 for 2000 and 2001, respectively). Unlike aflatoxin, BGYF was not affected by the year in which plants were grown. Selection for low levels of BGYF prior to selection based on aflatoxin concentration is as effective as selection for either factor alone. MI82 has value in programs designed to improve the resistance of commercially used corn inbreds.

Evaluation of Inoculation Techniques for Fusarium Ear Rot and Fumonisin Contamination of Corn.

Fumonisins have been associated with potentially serious toxicoses of animals and humans. Prior to initiating a corn (Zea mays) breeding program for resistance to these mycotoxins, an efficient inoculation technique must be developed. Four inoculation techniques were evaluated on 14 commercial corn hybrids in Urbana, IL in 1999 and 2000. The techniques were: injection of inoculum through the ear husk leaves at R2 (blister); silks sprayed with inoculum at R2 and covered with a shoot bag until harvest; silks sprayed with inoculum at R2, covered with a shoot bag, reinoculated 1 week thereafter, and covered with a shoot bag until harvest; and insertion of six Fusarium-colonized toothpicks into the silk channel at R2. Only injection of inoculum through the husk leaves significantly increased the concentration of fumonisin in grain and severity of Fusarium ear rot compared with a control. This technique effectively differentiated hybrids previously identified as resistant or susceptible to Fusarium ear rot. The rank order of hybrids inoculated with this technique did not significantly change in the 2 years of this study. This technique is suitable for efficiently evaluating a large number of corn genotypes for resistance to Fusarium ear rot and fumonisin concentration.

Quantitative trait Loci associated with resistance to gray leaf spot of corn.

ABSTRACT The susceptible parent FR1141, the resistant parent 061, the F1 cross, and 301 families selfed once from backcrosses to the susceptible parent were evaluated for gray leaf spot (GLS) severity for two years in Urbana, IL, and one year in Andrews, NC. Linkage between ear height and GLS severity was suspected. Therefore, plant height characteristics were noted for two years in Urbana, IL. Eighty-six polymorphic probes were used to construct a random fragment length polymorphism linkage map, and the presence, locations, effects, and interactions of quantitative trait loci (QTL) associated with GLS, plant and ear height were determined. Five QTL were significantly associated with GLS resistance across all environments and rating periods. These five regions are associated with additive effects on phenotype and account for between 51.0 and 58.7% of the phenotypic variation associated with GLS severity. Additionally, six QTL were identified with maturity-dependent associations to GLS severity. Heritability of GLS resistance was estimated to be approximately 0.73. Four QTL were identified with associations to ear height relative to total plant height. One of the four was associated with higher ear height and GLS resistance.

The Peperomia mitochondrial coxI group I intron: timing of horizontal transfer and subsequent evolution of the intron.

The Peperomia polybotrya coxI gene intron is the only currently reported group I intron in a vascular plant mitochondrial genome and it likely originated by horizontal transfer from a fungal donor. We provide a clearer picture of the horizontal transfer and a portrayal of the evolution of the group I intron since it was gained by the Peperomia mitochondrial genome. The intron was transferred recently in terms of plant evolution, being restricted to the single genus Peperomia among the order Piperales. Additional support is presented for the suggestion that a recombination/repair mechanism was used by the intron for integration into the Peperomia mitochondrial genome, as a perfect 1:1 correspondence exists between the intron's presence in a species and the presence of divergent nucleotide markers flanking the intron insertion site. Sequencing of coxI introns from additional Peperomia species revealed that several mutations have occurred in the intron since the horizontal transfer, but sequence alterations have not caused frameshifts or created stop codons in the intronic open reading frame. In addition, two coxI pseudogenes in Peperomia cubensis were discovered that lack a large region of coxI exon 2 and contain a truncated version of the group I intron that likely cannot be spliced out.

Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disorders.

Two hundred and eighty-two patients with congenital bleeding disorders received blood component replacement therapy between January 1979 and April 1985, were followed-up by the Puget Sound Blood Center's Hemophilia Care Program, and were tested for antibody to human immunodeficiency virus (HIV). Serologic results were obtained at least 1 year after the last exposure to volunteer donor products that were prepared before donor HIV screening or after the last exposure to concentrates produced before the manufacturer's use of treatment methods for inactivation of HIV. In all, 106 patients were anti-HIV positive. The risk of HIV infection was greater in patients with more severe bleeding tendencies, greater exposure to components, and exposure to lyophilized concentrates from large pools of donors. Of 100 patients with hemophilia A who only received cryoprecipitate from volunteer donors from Washington State (during the 6.3-year period), 14% had become anti-HIV positive. Of 27 patients receiving mostly cryoprecipitate but also being exposed to a single lot of concentrate during the same period, 13 (48%) were positive. Of 49 patients treated predominantly or solely with factor VIII concentrates during this period, 43 (88%) were anti-HIV positive. Of 29 patients with von Willebrand disease, four were anti-HIV positive, including 2 of 26 receiving only cryoprecipitate and two of three who had received a single dose of factor VIII concentrate. Of 19 patients who were treated solely with volunteer donor plasma, all remained anti-HIV negative. Of 47 patients exposed to factor IX concentrate, 28 (60%) were positive. Data relevant to the risk of HIV transmission subsequent to screening of the volunteer donor population were also obtained. Treatment records of 55 hemophilia A patients who have remained anti-HIV negative through at least June 1990 showed exposure to 71,173 screened donors from May 1985 through December 1989, and all 55 patients have remained anti-HIV negative.

Danazol fails to increase factor VIII or IX levels in a double-blind crossover study of patients with haemophilia A and B.

Twenty-one patients, 14 with haemophilia A and seven with haemophilia B, completed a double-blind crossover study to evaluate the effects of danazol on factor VIII and factor IX levels. Clotting and immunoradiometric assays were used to measure factor levels at baseline, 2 weeks and 8 weeks on both danazol and placebo. Fibrinogen, plasminogen and activated partial thromboplastin time were measured on all patients during placebo and danazol treatment. Although plasminogen levels rose significantly (P less than 0.01) and fibrinogen decreased (P less than 0.01), factor VIII and IX levels did not change. While on danazol, three patients had increased bleeding and shortened euglobulin lysis times compared to their baseline levels. We conclude that danazol does not raise factor VIII or IX levels and increases bleeding in some patients.

An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.

The influence of enzymic distribution on lidocaine metabolism was investigated in the once-through perfused rat liver preparation. Low input concentrations of 14C-lidocaine (1-2 microM) and preformed monoethylglycine xylidide (MEGX; 2.3-2.8 microM) were delivered by normal and retrograde flow directions to the liver preparations at 10 ml/min per liver. Upon reversal of normal to retrograde delivery of lidocaine, the rates at which lidocaine, MEGX, and glycine xylidide (GX) left the liver almost doubled, whereas the rates of appearance of (total) hydroxylated lidocaine and MEGX in bile and perfusate increased to lesser extents. Upon reversal of normal to retrograde delivery of preformed MEGX, the rates of appearance of MEGX and GX were virtually unchanged. Computer simulations on lidocaine and preformed MEGX metabolism were performed on both evenly distributed ("parallel tube" model) and enzyme-distributed systems. An even or parallel distribution of N-deethylation and hydroxylation activities for lidocaine metabolism failed to predict the observed increased hepatic availability of lidocaine. Rather, the distribution of a low-affinity, high-capacity N-deethylation system anterior to a high-affinity, low-capacity hydroxylation system for lidocaine metabolism adequately predicted the increased hepatic availability of lidocaine. Further extension of these consistent enzyme-distributed models on the metabolism of lidocaine metabolites suggests that the N-deethylation and hydroxylation activities for the metabolism of lidocaine, MEGX, 3-hydroxyidocaine, and 3-hydroxy MEGX are not identically distributed. When these enzyme-distributed models were appraised with reference to the "parallel tube" and "well-stirred" models of hepatic drug clearance, predictions from these enzyme-distributed models proved to be superior to the "parallel tube" and "well-stirred" models for the present data on lidocaine metabolites with normal and retrograde perfusions. Previously published data on lidocaine and MEGX metabolism after inputting 4 micrograms/ml (17 microM) lidocaine at flow rates of 10, 12, 14, and 16 ml/min were reexamined with respect to the adequacy of these enzyme-distributed models. They were found to be superior to the evenly-distributed or "parallel tube" model in predicting hepatic availability of lidocaine and the rate of appearance of MEGX. However, the enzyme-distributed systems were not as consistent as the "well-stirred" model in predicting lidocaine hepatic availability in these flow experiments.

Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.

Dantrolene sodium, a hydantoin analogue, is efficacious in the therapy of malignant hyperthermia (MH). In order to improve our knowledge of the mode of action of dantrolene, we have examined the influence of dantrolene sodium on: (1) twitch and resting tensions, in the absence and the presence of caffeine, of intact skeletal muscle fascicles; and (2) caffeine induced tension rises of single chemically skinned skeletal muscle fascicles. We have found that dantrolene appears to exert its beneficial action on malignant hyperthermia susceptible (MHS) skeletal muscle by an indirect action on the sarcoplasmic reticulum (SR). Thus dantrolene inhibits twitch tensions of skeletal muscle fascicles, probably by indirectly preventing the release of calcium from the SR. To a lesser extent dantrolene inhibits caffeine induced contractures of skeletal muscle fascicles, probably by indirectly accelerating the uptake of calcium into the SR. Because the former effect is greater than the latter in vivo dantrolene sodium is effective only when given prior to total loss of calcium from the SR. Vigilant temperature and EKG monitoring of all patients during anaesthesia is, therefore, essential.

Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.

We have compared and contrasted two diagnostic tests for Malignant Hyperthermia (MH) - the Caffeine-Halothane Contracture Test and the Caffeine Skinned Fibre Tension Test. Both tests show a strongly positive relationship both with the occurrence of MH reactions and with each other. The former test is more rapid and requires less skill. The latter test can be performed on much less muscle and permits storage of the muscle over prolonged periods of time.